John Öhd,
The second quarter in figures
- The loss after tax amounted to TSEK 4 695 (2 992).
- The loss per share amounted to
SEK 0,29 (0,19). - The cash flow from current operations was negative in the amount of TSEK 4 267 (3 228).
The first half-year in figures
- The loss after tax amounted to TSEK 10 735 (6 057).
- The loss per share amounted to
SEK 0,67 (0,38). - The cash flow from current operations was negative in the amount of TSEK 10 602 (10 773).
Important events during the second quarter
Modus Therapeutics participated in LSX,London .- The annual general meeting was held on
May 11 . Modus Therapeutics presented new data on sevuparin demonstrating its potential to treat anemia related to chronic inflammation and kidney disease at the annualEuropean Hematology Association Congress .
Important events after the end of the period
No events to report.
CEO John Öhd will provide comments on the report in an interview with Jonathan Furelid today
© Modular Finance, source